clorazepate dipotassium has been researched along with Chemical Dependence in 9 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 4 (44.44) | 18.7374 |
| 1990's | 2 (22.22) | 18.2507 |
| 2000's | 3 (33.33) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dervaux, A; Kanit, M; Laqueille, X; Launay, C | 1 |
| Capasso, A; Cavallo, F; Raffa, RB | 1 |
| Capasso, A; Cavallo, F; Ding, Z; Raffa, RB; Rawls, SM | 1 |
| Sussman, N | 1 |
| Davis, NH | 1 |
| Salomon, C | 1 |
| Miller, RR | 1 |
| Kaistha, KK; Tadrus, R | 1 |
2 review(s) available for clorazepate dipotassium and Chemical Dependence
| Article | Year |
|---|---|
[Abuse of alcohol and benzodiazepine during substitution therapy in heroin addicts: a review of the literature].
Topics: Adolescent; Adult; Alcoholism; Benzodiazepines; Buprenorphine; Clonazepam; Clorazepate Dipotassium; Comorbidity; Controlled Clinical Trials as Topic; Diazepam; Dose-Response Relationship, Drug; Drug Synergism; Drug Therapy, Combination; Ethanol; Euphoria; Flunitrazepam; Heroin Dependence; Humans; Metabolic Clearance Rate; Methadone; Narcotics; Substance-Related Disorders; Young Adult | 2009 |
Treating anxiety while minimizing abuse and dependence.
Topics: Alprazolam; Anti-Anxiety Agents; Anxiety Disorders; Benzodiazepines; Buspirone; Clorazepate Dipotassium; Humans; Substance Withdrawal Syndrome; Substance-Related Disorders | 1993 |
7 other study(ies) available for clorazepate dipotassium and Chemical Dependence
| Article | Year |
|---|---|
Flumazenil-sensitive dose-related physical dependence in planarians produced by two benzodiazepine and one non-benzodiazepine benzodiazepine-receptor agonists.
Topics: Analysis of Variance; Animals; Benzodiazepines; Clorazepate Dipotassium; Dose-Response Relationship, Drug; Flumazenil; GABA Agonists; GABA Modulators; Locomotion; Midazolam; Planarians; Pyridines; Receptors, GABA-A; Reproducibility of Results; Substance Withdrawal Syndrome; Substance-Related Disorders; Zolpidem | 2007 |
The beta-lactam antibiotic ceftriaxone inhibits physical dependence and abstinence-induced withdrawal from cocaine, amphetamine, methamphetamine, and clorazepate in planarians.
Topics: Amphetamine; Amphetamine-Related Disorders; Animals; Anti-Bacterial Agents; Ceftriaxone; Clorazepate Dipotassium; Cocaine; Cocaine-Related Disorders; Dose-Response Relationship, Drug; Excitatory Amino Acid Transporter 2; Methamphetamine; Models, Animal; Motor Activity; Planarians; Substance Withdrawal Syndrome; Substance-Related Disorders; Time Factors | 2008 |
Systematic review of the benzodiazepines. Guidelines for data sheets on diazepam, chlordiazepoxide, medazepam, clorazepate, lorazepam, oxazepam, temazepam, triazolam, nitrazepam, and flurazepam. Committee on the Review of Medicines.
Topics: Benzodiazepines; Chlordiazepoxide; Clorazepate Dipotassium; Diazepam; Flurazepam; Humans; Lorazepam; Medazepam; Nitrazepam; Oxazepam; Safety; Substance Withdrawal Syndrome; Substance-Related Disorders; Temazepam; Triazolam | 1980 |
Change from zolpidem to clorazepate won't solve the patient's problem.
Topics: Anti-Anxiety Agents; Clorazepate Dipotassium; Drug Tolerance; Humans; Hypnotics and Sedatives; Pyridines; Substance-Related Disorders; Zolpidem | 1997 |
[Study of flunitrazepam in a psychiatric practice].
Topics: Acepromazine; Anti-Anxiety Agents; Barbiturates; Clorazepate Dipotassium; Drug Combinations; Drug Tolerance; Flunitrazepam; Humans; Meprobamate; Methaqualone; Nitrazepam; Psychiatric Department, Hospital; Quinazolines; Sleep; Substance-Related Disorders; Time Factors | 1979 |
A guide to the use of hypnotic drugs.
Topics: Benzodiazepines; Chlordiazepoxide; Clorazepate Dipotassium; Diazepam; Drug Interactions; Flurazepam; Humans; Hypnotics and Sedatives; Sleep Wake Disorders; Substance-Related Disorders | 1979 |
Thin-layer detection of diazepam and/or chilordiazepoxide alone or in combination with major drugs of abuse in drug abuse urine screening programs.
Topics: Chlordiazepoxide; Chromatography, Thin Layer; Clorazepate Dipotassium; Diazepam; Humans; Indicators and Reagents; Mass Screening; Oxazepam; Substance-Related Disorders | 1978 |